Trials / Unknown
UnknownNCT04938479
D-dimer Prognostic Marker of Cerebral Infarction After Revascularization Procedure
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Cerebral infarction is the leading cause of acquired disability in adults. Absence of biological marker used in current practice and identified as a prognostic factor for recovery. D-dimers are degradation products of stabilized fibrin translating an activation of coagulation whatever the cause. Studies have shown that increased D-dimer levels in patients with MI is associated with a higher mortality rate, the link with post-intervention non-revascularization has been demonstrate. The purpose of this project is to search for a correlation between the level of D-dimer and the degree of recovery evaluated by the NIHSS score
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | blood sample | D-dimer measurement in blood sample |
Timeline
- Start date
- 2021-06-15
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
- First posted
- 2021-06-24
- Last updated
- 2023-05-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04938479. Inclusion in this directory is not an endorsement.